StemExpress was founded in 2010 to accelerate the cure and prevention of significant medical conditions at life-changing speed. StemExpress supports cell and gene therapies, commercialization of disease specific treatments, medical research, clinical trials, precision/regenerative medicine, among other researchers and clinicians around the world who are developing and implementing revolutionary treatments and cures.